Cohen JA, Comi G, Selmaj KW, et al. Ozanimod vs interferon β-1a: clinical and MRI results of RADIANCE part B - A 2-year Phase 3 trial in relapsing multiple sclerosis. ECTRIMS 2017, 280.
MS-patiënten hebben geen verhoogde kans op COVID-19
nov 2020 | Multipele Sclerose